ISHITA DRUGS & INDUSTRIES LTD.

Company Profile

ISHITA DRUGS & INDUSTRIES LTD. had its IPO on under the ticker symbol ISHITADR.

The company operates in the sector and industry. ISHITA DRUGS & INDUSTRIES LTD. has a staff strength of 0 employees.

Stock update

Shares of ISHITA DRUGS & INDUSTRIES LTD. opened at ₹72.42 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹67.45 - ₹72.42, and closed at ₹69.

This is a -2.82% slip from the previous day's closing price.

A total volume of 921 shares were traded at the close of the day’s session.

In the last one week, shares of ISHITA DRUGS & INDUSTRIES LTD. have increased by +3.65%.

ISHITA DRUGS & INDUSTRIES LTD.'s Key Ratios

ISHITA DRUGS & INDUSTRIES LTD. has a market cap of ₹218.74 million, indicating a price to book ratio of 1.7748 and a price to sales ratio of 1.0854.

In the last 12-months ISHITA DRUGS & INDUSTRIES LTD.’s revenue was ₹0 with a gross profit of ₹18.67 million and an EBITDA of ₹0. The EBITDA ratio measures ISHITA DRUGS & INDUSTRIES LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, ISHITA DRUGS & INDUSTRIES LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, ISHITA DRUGS & INDUSTRIES LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

ISHITA DRUGS & INDUSTRIES LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

42.5538

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ISHITA DRUGS & INDUSTRIES LTD.’s profitability.

ISHITA DRUGS & INDUSTRIES LTD. stock is trading at a EV to sales ratio of 0.6346 and a EV to EBITDA ratio of 7.7945. Its price to sales ratio in the trailing 12-months stood at 1.0854.

ISHITA DRUGS & INDUSTRIES LTD. stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹114.07 million

Total Liabilities

₹22.13 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

ISHITA DRUGS & INDUSTRIES LTD. ended 2025 with ₹114.07 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹114.07 million while shareholder equity stood at ₹91.73 million.

ISHITA DRUGS & INDUSTRIES LTD. ended 2025 with ₹0 in deferred long-term liabilities, ₹22.13 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹6.06 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.

ISHITA DRUGS & INDUSTRIES LTD.’s total current assets stands at ₹101.78 million while long-term investments were ₹0 and short-term investments were ₹59.72 million. Its net receivables were ₹18.00 million compared to accounts payable of ₹8.55 million and inventory worth ₹15.98 million.

In 2025, ISHITA DRUGS & INDUSTRIES LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, ISHITA DRUGS & INDUSTRIES LTD. paid ₹0 in dividends in 2025.

Other key metrics

Current Trading Price

₹69

52-Week High

₹88.9

52-Week Low

₹41.1

Analyst Target Price

₹

ISHITA DRUGS & INDUSTRIES LTD. stock is currently trading at ₹69 per share. It touched a 52-week high of ₹88.9 and a 52-week low of ₹88.9. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹72.28 and 200-day moving average was ₹58.33 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.